These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16725119)

  • 1. Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia.
    De Luca V; Tharmalingam S; Müller DJ; Wong G; de Bartolomeis A; Kennedy JL
    Brain Res; 2006 Jun; 1097(1):26-30. PubMed ID: 16725119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-gene interaction between MAOA and COMT in suicidal behavior.
    De Luca V; Tharmalingam S; Sicard T; Kennedy JL
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):151-4. PubMed ID: 15936529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis.
    Norton N; Kirov G; Zammit S; Jones G; Jones S; Owen R; Krawczak M; Williams NM; O'Donovan MC; Owen MJ
    Am J Med Genet; 2002 Jul; 114(5):491-6. PubMed ID: 12116182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
    Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-gene interaction between COMT and MAOA potentially predicts the intelligence of attention-deficit hyperactivity disorder boys in China.
    Qian QJ; Yang L; Wang YF; Zhang HB; Guan LL; Chen Y; Ji N; Liu L; Faraone SV
    Behav Genet; 2010 May; 40(3):357-65. PubMed ID: 19941049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior.
    Tochigi M; Suzuki K; Kato C; Otowa T; Hibino H; Umekage T; Kato N; Sasaki T
    Pharmacogenet Genomics; 2007 Oct; 17(10):867-72. PubMed ID: 17885625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
    Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
    Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT.
    Doornbos B; Dijck-Brouwer DA; Kema IP; Tanke MA; van Goor SA; Muskiet FA; Korf J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1250-4. PubMed ID: 19625011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families.
    Chen X; Wang X; O'Neill AF; Walsh D; Kendler KS
    Mol Psychiatry; 2004 Oct; 9(10):962-7. PubMed ID: 15124004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamines and aggression: the role of COMT and MAO polymorphisms.
    Volavka J; Bilder R; Nolan K
    Ann N Y Acad Sci; 2004 Dec; 1036():393-8. PubMed ID: 15817751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET).
    Rybakowski JK; Borkowska A; Czerski PM; Dmitrzak-Weglarz M; Skibinska M; Kapelski P; Hauser J
    Psychiatry Res; 2006 Jun; 143(1):13-9. PubMed ID: 16712949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between catechol-O-methyl-transferase Val108/158Met polymorphism and suicide.
    Pivac N; Pregelj P; Nikolac M; Zupanc T; Nedic G; Muck Seler D; Videtic Paska A
    Genes Brain Behav; 2011 Jul; 10(5):565-9. PubMed ID: 21486391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies.
    Joo EJ; Jeong SH; Ahn YM; Lee KY; Chang Yoon S; Kim EJ; Kim SU; Cho SC; Sik Kim Y
    Psychiatry Res; 2005 Sep; 136(2-3):83-91. PubMed ID: 16109444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
    Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of association between personality traits and three functional polymorphisms in the tyrosine hydroxylase, monoamine oxidase A, and catechol-O-methyltransferase genes.
    Tochigi M; Otowa T; Hibino H; Kato C; Otani T; Umekage T; Utsumi T; Kato N; Sasaki T
    Neurosci Res; 2006 Mar; 54(3):180-5. PubMed ID: 16360899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyl transferase and schizophrenia.
    Sagud M; Mück-Seler D; Mihaljević-Peles A; Vuksan-Cusa B; Zivković M; Jakovljević M; Pivac N
    Psychiatr Danub; 2010 Jun; 22(2):270-4. PubMed ID: 20562760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population.
    Nunokawa A; Watanabe Y; Muratake T; Kaneko N; Koizumi M; Someya T
    Neurosci Res; 2007 Jul; 58(3):291-6. PubMed ID: 17482701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behaviour.
    De Luca V; Strauss J; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):197-203. PubMed ID: 17869399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.